Finally, they demonstrated that plasma levels of sHLA-G were higher in patients than in healthy controls, and sHLA-G levels inversely correlated to numbers of peripheral activated T cells, thus suggesting that sHLA-G promotes tumor immune escape through the inactivation T cell responses [32]. This evidence concerns the gene HLA-G and neoplasm.